SB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Menon, Manoj B ^a   Kotlyarov, Alexey ^a   Gaestel, Matthias ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN P62; PROTEIN S6; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; RAPAMYCIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL VACUOLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOUSE; MUTANT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; ANIMAL; ANTIBODY SPECIFICITY; CELL TRANSFORMATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; HAMSTER; LYSOSOME; METABOLISM; PATHOLOGY; PHAGOSOME; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CRICETINAE; RATTUS;

ANIMALS; AUTOPHAGY; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CRICETINAE; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMIDAZOLES; LYSOSOMES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; ORGAN SPECIFICITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOSOMES; PROTEIN KINASE INHIBITORS; PROTEOLYSIS; PYRIDINES; RATS; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSCRIPTION, GENETIC; VACUOLES;

EID: 80051540934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023054     Document Type: Article

References (54)

1. Gaestel M, Mengel A, Bothe U, Asadullah K, (2007) Protein kinases as small molecule inhibitor targets in inflammation. Curr Med Chem 14: 2214-2234.
2. Zhang J, Yang PL, Gray NS, (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9: 28-39.
3. Yong HY, Koh MS, Moon A, (2009) The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 18: 1893-1905.
4. Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ, et al. (1998) Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem 273: 15605-15610.
5. Eyers PA, Craxton M, Morrice N, Cohen P, Goedert M, (1998) Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. Chem Biol 5: 321-328.
6. Lali FV, Hunt AE, Turner SJ, Foxwell BM, (2000) The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem 275: 7395-7402.
7. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, et al. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315.
8. Laufer SA, Wagner GK, Kotschenreuther DA, Albrecht W, (2003) Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem 46: 3230-3244.
9. Borsch-Haubold AG, Pasquet S, Watson SP, (1998) Direct inhibition of cyclooxygenase-1 and-2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 273: 28766-28772.
10. Comes F, Matrone A, Lastella P, Nico B, Susca FC, et al. (2007) A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ 14: 693-702.
11. Matrone A, Grossi V, Chiacchiera F, Fina E, Cappellari M, et al. (2010) p38alpha is required for ovarian cancer cell metabolism and survival. Int J Gynecol Cancer 20: 203-211.
12. Mizushima N, Levine B, (2010) Autophagy in mammalian development and differentiation. Nat Cell Biol 12: 823-830.
13. Mehrpour M, Esclatine A, Beau I, Codogno P, (2010) Overview of macroautophagy regulation in mammalian cells. Cell Res 20: 748-762.
14. Jung CH, Ro SH, Cao J, Otto NM, Kim DH, (2010) mTOR regulation of autophagy. FEBS Lett 584: 1287-1295.
15. Corcelle E, Nebout M, Bekri S, Gauthier N, Hofman P, et al. (2006) Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res 66: 6861-6870.
16. Simone C, (2007) Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy 3: 468-471.
17. Prick T, Thumm M, Kohrer K, Haussinger D, Vom Dahl S, (2006) In yeast, loss of Hog1 leads to osmosensitivity of autophagy. Biochem J 394: 153-161.
18. Webber JL, Tooze SA, (2010) Coordinated regulation of autophagy by p38[alpha] MAPK through mAtg9 and p38IP. EMBO J 29: 27-40.
19. Chiacchiera F, Matrone A, Ferrari E, Ingravallo G, Lo Sasso G, et al. (2009) p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ 16: 1203-1214.
20. Tanida I, Ueno T, Kominami E, (2008) LC3 and Autophagy. Methods Mol Biol 445: 77-88.
21. Mizushima N, Yoshimori T, Levine B, (2010) Methods in mammalian autophagy research. Cell 140: 313-326.
22. Chiacchiera F, Simone C, (2010) The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle 9.
23. Tang G, Yue Z, Talloczy Z, Hagemann T, Cho W, et al. (2008) Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum Mol Genet 17: 1540-1555.
24. Corcelle E, Djerbi N, Mari M, Nebout M, Fiorini C, et al. (2007) Control of the autophagy maturation step by the MAPK ERK and p38: lessons from environmental carcinogens. Autophagy 3: 57-59.
25. Szyniarowski P, Corcelle-Termeau E, Farkas T, Hoyer-Hansen M, Nylandsted J, et al. (2011) A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditions. Autophagy 7.
26. Eyers PA, van den IP, Quinlan RA, Goedert M, Cohen P, (1999) Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. FEBS Lett 451: 191-196.
27. Son JK, Varadarajan S, Bratton SB, (2010) TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Cell Death Differ 17: 1288-1301.
28. Menon MB, Schwermann J, Singh AK, Franz-Wachtel M, Pabst O, et al. (2010) p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. J Biol Chem 285: 33242-33251.
29. Sakiyama T, Musch MW, Ropeleski MJ, Tsubouchi H, Chang EB, (2009) Glutamine increases autophagy under Basal and stressed conditions in intestinal epithelial cells. Gastroenterology 136: 924-932.
30. Matrone A, Grossi V, Chiacchiera F, Fina E, Cappellari M, et al. (2010) p38alpha is required for ovarian cancer cell metabolism and survival. Int J Gynecol Cancer 20: 203-211.
31. McClung JM, Judge AR, Powers SK, Yan Z, (2010) p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am J Physiol Cell Physiol 298: C542-549.
32. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, et al. (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132.
33. Fabian MA, Biggs WH 3rd, Treiber DK, Atteridge CE, Azimioara MD, et al. (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23: 329-336.
34. Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke S, et al. (2003) An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci U S A 100: 15434-15439.
35. Davies SP, Reddy H, Caivano M, Cohen P, (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
36. Maddodi N, Huang W, Havighurst T, Kim K, Longley BJ, et al. (2010) Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol 130: 1657-1667.
37. He S, Wang L, Miao L, Wang T, Du F, et al. (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100-1111.
38. Kametaka S, Moriyama K, Burgos PV, Eisenberg E, Greene LE, et al. (2007) Canonical interaction of cyclin G associated kinase with adaptor protein 1 regulates lysosomal enzyme sorting. Mol Biol Cell 18: 2991-3001.
39. Scott RC, Juhasz G, Neufeld TP, (2007) Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Curr Biol 17: 1-11.
40. Yang J, Takahashi Y, Cheng E, Liu J, Terranova PF, et al. (2010) GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J Cell Sci 123: 861-870.
41. Brown WJ, DeWald DB, Emr SD, Plutner H, Balch WE, (1995) Role for phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells. J Cell Biol 130: 781-796.
42. Bawolak MT, Morissette G, Marceau F, (2010) Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes. Can J Anaesth 57: 230-239.
43. Hsu PP, Sabatini DM, (2008) Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
44. King AJ, Patrick DR, Batorsky RS, Ho ML, Do HT, et al. (2006) Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res 66: 11100-11105.
45. Tsai J, Lee JT, Wang W, Zhang J, Cho H, et al. (2008) Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proceedings of the National Academy of Sciences 105: 3041-3046.
46. Solit DB, Garraway LA, Pratilas CA, Sawai A, Getz G, et al. (2006) BRAF mutation predicts sensitivity to MEK inhibition. Nature 439: 358-362.
47. Lin R, Murtazina R, Cha B, Chakraborty M, Sarker R, et al. (2011) D-glucose acts via sodium/glucose cotransporter 1 to increase NHE3 in mouse jejunal brush border by a Na+/H+ exchange regulatory factor 2-dependent process. Gastroenterology 140: 560-571.
48. Singh AK, Manns MP, Seidler U, (2011) Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin. Cell Mol Life Sci 68: 1041-1051.
49. Hsu M-Y, Elder D, Herlyn M, (2002) Melanoma: The Wistar Melanoma (WM) Cell Lines. In: Masters JRW, Palsson B, editors. Human Cell Culture Springer Netherlands pp. 259-274.
50. Ross RA, Spengler BA, Biedler JL, (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71: 741-747.
51. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, et al. (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457.
52. Ronkina N, Menon MB, Schwermann J, Arthur JS, Legault H, et al. (2010) Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes. Nucleic Acids Res.
53. Storz P, Doppler H, Toker A, (2005) Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol Cell Biol 25: 8520-8530.
54. Ehrhardt C, Schmolke M, Matzke A, Knoblauch A, Will C, et al. (2006) Polyethylenimine, a cost-effective transfection reagent. Signal Transduction 6: 179-184.